Search

The charge storage mechanism and capacity of supercapacitors completely depend on the electrochemical and mechanical properties of electrode materials. Herein, continuously reinforced carbon nanotube film (CNTF), as the flexible support layer and the conductive skeleton, was prepared via the floating catalytic chemical vapor deposition (FCCVD) method. Furthermore, a series of novel flexible self-supporting CNTF/polyaniline (PANI) nanocomposite electrode materials were prepared by cyclic voltammetry electrochemical polymerization (CVEP), with aniline and mixed-acid-treated CNTF film. By controlling the different polymerization cycles, it was found that the growth model, morphology, apparent color, and loading amount of the PANI on the CNTF surface were different. The CNTF/PANI-15C composite electrode, prepared by 15 cycles of electrochemical polymerization, has a unique surface, with a “sea-cucumber-like” 3D nanoprotrusion structure and microporous channels formed via the stacking of the PANI nanowires. A CNTF/PANI-15C flexible electrode exhibited the highest specific capacitance, 903.6 F/g, and the highest energy density, 45.2 Wh/kg, at the current density of 1 A/g and the voltage window of 0 to 0.6 V. It could maintain 73.9% of the initial value at a high current density of 10 A/g. The excellent electrochemical cycle and structural stabilities were confirmed on the condition of the higher capacitance retention of 95.1% after 2000 cycles of galvanostatic charge/discharge, and on the almost unchanged electrochemical performances after 500 cycles of bending. The tensile strength of the composite electrode was 124.5 MPa, and the elongation at break was 18.9%.

Tricyclic alkaloid-like compounds were synthesised in a few steps, via the bridging Ritter reaction., Tricyclic alkaloid-like compounds were synthesised in a few steps, via the bridging Ritter reaction. The compounds were evaluated for their antiproliferative activity against the MCF-7 and the aggressive MDA-MB-231 breast cancer cells. The anti-cancer activities of 2c were found to be selective towards the aggressive and more challenging to treat triple negative (MDA-MB-231) cell line while exhibiting no antiproliferative activities towards the MCF-7 cells at the highest concentration tested (50 μM). The IC50 of compound 2c was determined to be 7.9 μM for the MDA-MB-231 cell line. Furthermore, 2c arrested cell cycle at the G2/M phase and induced apoptosis in a dose-dependent manner. Besides in-house anti-cancer screening, compound 3 was selected for anti-cancer screening by the National Cancer Institute and was found to have broad anti-cancer activity with selectivity against particular leukaemia, colon, melanoma, and breast cancer cell lines. Cytotoxicities of compounds 2c and 3 were also tested against noncancerous mammalian cells (VERO cell line), and found to be selective towards cancerous cells. The facile synthetic route, unique chemical structures and the biological data make these alkaloid-like compounds worthwhile lead compounds for further anti-cancer drug development.

Huidan Zhang,* Dongju Han,* Tongtong Lv, Kehang Liu, Yunqing Yang, Xixi Xu, Yuqing ChenDepartment of Biochemistry, Life Sciences College, Nanjing Normal University, Nanjing, People’s Republic of China*These authors contributed equally to this workPurpose: There is an urgent need for the development of novel, effective, and less toxic drugs to treat leukemia. Antimicrobial peptides (AMPs) have received much more attention as alternative chemotherapeutic agents. This study aimed to examined the cytotoxicity of a novel AMP myristoly-CM4 against chronic myeloid leukemia cells (K562/MDR) and acute lymphocytic leukemia cells (Jurkat), and further investigated its selectivity to clarify the cytotoxic mechanism.Materials and methods: In this study, the cytotoxicity and selectivity of myristoly-CM4 against K562/MDR and Jurkat cells were assessed in vitro, and the anticancer mechanism responsible for its cytotoxicity and selectivity was further investigated.Results: Myristoly-CM4 was cytotoxic to these leukemia cell lines (IC50 2–4 μM) and was less cytotoxic to normal cells (HEK-293, L02 cells, peripheral blood mononuclear cells, and erythrocytes). Myristoyl-CM4 had stronger affinity to K562/MDR and Jurkat cells than to normal cells, while the contents of phosphatidylserine and sialic acids on the cell surfaces of K562/MDR and Jurkat cells were significantly higher than that of HEK293 cells. The myristoyl group effectively mediated the internalization of myristoyl-CM4 to leukemia cells. After internalization, myristoyl-CM4 could target mitochondria and affected mitochondrial function, including disruption of Δψm, increasing the accumulation of ROS, increasing the Bax/Bcl-2 ratio, activating caspase 9 and 3, and PARP to induce mitochondria-dependent apoptosis in both K562/MDR and Jurkat cells. Myristoyl-CM4 also induced K562/MDR cell necrosis by directive membrane disruption, and significantly decreased the level of P-glycoprotein in K562/MDR cells.Conclusion: These results suggested that myristoyl-CM4 showed selective cytotoxicity to leukemia K562/MDR and Jurkat cells by apoptosis and/or necrosis pathway. Myristoyl-CM4, thus, appears to be a promising candidate for leukemia treatment, including multidrug-resistant leukemia.Keywords: leukemia, multi-drug resistance, necrosis, apoptosis, myristoyl-CM4, selectivity &nbsp